ER21355
ER21355 is an inhibitor of phosphodiesterase 5 (PDE5), used for treatment of prostatic diseases.
Product Specifications
CAS Number
150452-18-9
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ER21355.html
Solubility
10 mM in DMSO
Smiles
O=C(C1CCN(C2=NC(NCC3=CC=C(OCO4)C4=C3)=C5C=C(Cl)C=CC5=N2)CC1)O
Molecular Formula
C22H21ClN4O4
Molecular Weight
440.88
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501
References & Citations
[1]Wolf-Georg Forssmann, et al. Use of phosphodiesterase inhibitors in the treatment of prostatic diseases. US 8106061 B2
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE5
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
050163-01 10 µg
Bcl2 Associated Athanogene 1 (BAG1), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 050163-02 50 µg
Bcl2 Associated Athanogene 1 (BAG1), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 050163-03 100 µg
Bcl2 Associated Athanogene 1 (BAG1), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 050163-04 200 µg
Bcl2 Associated Athanogene 1 (BAG1), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 